Literature DB >> 17609321

Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India.

Jessica Keen1, Gabriella A Farcas, Kathleen Zhong, Seychelle Yohanna, Michael W Dunne, Kevin C Kain.   

Abstract

Chloroquine-resistant Plasmodium falciparum (CRPF) malaria isolates in Southeast Asia and sub-Saharan Africa share the same Plasmodium falciparum chloroquine resistance transporter (PfCRT) haplotype (CVIET; amino acids 72 to 76). It is believed that CRPF malaria emerged in Southeast Asia and spread to sub-Saharan Africa via the Indian subcontinent. Based on this assumption, we hypothesized that CRPF isolates in India should possess the same drug resistance haplotype (PfCRT haplotype CVIET) as P. falciparum isolates in Southeast Asia and Africa and that the prevalence of CRPF may be higher and more widespread in India than appreciated. To test this postulate, we utilized a standardized real-time PCR assay to assess the prevalence and distribution of PfCRT haplotypes in P. falciparum isolates (n = 406) collected from Western, Central, and Eastern states in India and compared them to isolates from South America and Africa. Based on the proportion of isolates possessing the molecular marker K76T, the prevalence of chloroquine resistance was high in all five regions of India studied (91%), as well as in Uganda (98%) and Suriname (100%). All isolates from Suriname contained the chloroquine-resistant SVMNT haplotype typical of South American isolates, and 98% of isolates from Uganda possessed the chloroquine-resistant CVIET haplotype characteristic of Southeast Asian/African strains. However, of 246 P. falciparum isolates from across India that contained the molecular marker for chloroquine resistance, 81% contained the SVMNT haplotype. In conclusion, the prevalence of CRPF malaria was high in geographically dispersed regions of India, and the primary haplotype observed, SVMNT, did not support a presumed geographic spread from contiguous Southeast Asia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609321      PMCID: PMC2045286          DOI: 10.1128/JCM.02291-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.

Authors:  D A Fidock; T Nomura; A K Talley; R A Cooper; S M Dzekunov; M T Ferdig; L M Ursos; A B Sidhu; B Naudé; K W Deitsch; X Z Su; J C Wootton; P D Roepe; T E Wellems
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

2.  Plasmodium chloroquine resistance and the search for a replacement antimalarial drug.

Authors:  Thomas E Wellems
Journal:  Science       Date:  2002-10-04       Impact factor: 47.728

Review 3.  Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of P. falciparum.

Authors:  J M Carlton; D A Fidock; A Djimdé; C V Plowe; T E Wellems
Journal:  Curr Opin Microbiol       Date:  2001-08       Impact factor: 7.934

Review 4.  Chloroquine-resistant malaria.

Authors:  T E Wellems; C V Plowe
Journal:  J Infect Dis       Date:  2001-08-07       Impact factor: 5.226

5.  Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers.

Authors:  D R Pillai; A C Labbé; V Vanisaveth; B Hongvangthong; S Pomphida; S Inkathone; K Zhong; K C Kain
Journal:  J Infect Dis       Date:  2001-02-01       Impact factor: 5.226

6.  Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America.

Authors:  R K Mehlotra; H Fujioka; P D Roepe; O Janneh; L M Ursos; V Jacobs-Lorena; D T McNamara; M J Bockarie; J W Kazura; D E Kyle; D A Fidock; P A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

7.  Origin of Plasmodium falciparum malaria is traced by mitochondrial DNA.

Authors:  D J Conway; C Fanello; J M Lloyd; B M Al-Joubori; A H Baloch; S D Somanath; C Roper; A M Oduola; B Mulder; M M Povoa; B Singh; A W Thomas
Journal:  Mol Biochem Parasitol       Date:  2000-11       Impact factor: 1.759

Review 8.  Epidemiology of drug-resistant malaria.

Authors:  Chansuda Wongsrichanalai; Amy L Pickard; Walther H Wernsdorfer; Steven R Meshnick
Journal:  Lancet Infect Dis       Date:  2002-04       Impact factor: 25.071

9.  A molecular marker for chloroquine-resistant falciparum malaria.

Authors:  A Djimdé; O K Doumbo; J F Cortese; K Kayentao; S Doumbo; Y Diourté; D Coulibaly; A Dicko; X Z Su; T Nomura; D A Fidock; T E Wellems; C V Plowe
Journal:  N Engl J Med       Date:  2001-01-25       Impact factor: 91.245

10.  Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum.

Authors:  John C Wootton; Xiaorong Feng; Michael T Ferdig; Roland A Cooper; Jianbing Mu; Dror I Baruch; Alan J Magill; Xin-Zhuan Su
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

View more
  17 in total

1.  Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay.

Authors:  Rina P M Wong; Harin Karunajeewa; Ivo Mueller; Peter Siba; Peter A Zimmerman; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.

Authors:  Olusola Ojurongbe; Segun I Oyedeji; Wellington A Oyibo; Adetola F Fagbenro-Beyioku; Jürgen F Kun
Journal:  Wien Klin Wochenschr       Date:  2010-11-12       Impact factor: 1.704

3.  Detection of Plasmodium vivax by nested PCR and real-time PCR.

Authors:  Ahmet Genc; Fadime Eroglu; Ismail Soner Koltas
Journal:  Korean J Parasitol       Date:  2010-06-17       Impact factor: 1.341

4.  Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.

Authors:  Bianca E Gama; Guilhermina A L Pereira-Carvalho; Florbela J I Lutucuta Kosi; Natália K Almeida de Oliveira; Filomeno Fortes; Philip J Rosenthal; Cláudio T Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Malar J       Date:  2010-06-18       Impact factor: 2.979

5.  Rapid identification of chloroquine and atovaquone drug resistance in Plasmodium falciparum using high-resolution melt polymerase chain reaction.

Authors:  Linda Seo Hwee Gan; Jin Phang Loh
Journal:  Malar J       Date:  2010-05-21       Impact factor: 2.979

6.  Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.

Authors:  Laura K Certain; Marnie Briceño; Steven M Kiara; Alexis M Nzila; William M Watkins; Carol Hopkins Sibley
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

7.  Lack of evidence for chloroquine-resistant Plasmodium falciparum malaria, Leogane, Haiti.

Authors:  Ami Neuberger; Kathleen Zhong; Kevin C Kain; Eli Schwartz
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883

8.  Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.

Authors:  Samir Ranjitkar; Mette L Schousboe; Thomas Thyge Thomsen; Madhav Adhikari; Christian M O Kapel; Ib C Bygbjerg; Michael Alifrangis
Journal:  Malar J       Date:  2011-04-01       Impact factor: 2.979

9.  Clinical trial of extended-dose chloroquine for treatment of resistant falciparum malaria among Afghan refugees in Pakistan.

Authors:  Natasha Howard; Naeem Durrani; Sanda Sanda; Khalid Beshir; Rachel Hallett; Mark Rowland
Journal:  Malar J       Date:  2011-06-23       Impact factor: 2.979

10.  Mutant pfcrt "SVMNT" haplotype and wild type pfmdr1 "N86" are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure.

Authors:  Prashant K Mallick; Hema Joshi; Neena Valecha; Surya K Sharma; Alex Eapen; Rajendra M Bhatt; Harish C Srivastava; Patrick L Sutton; Aditya P Dash; Virendra K Bhasin
Journal:  Malar J       Date:  2012-01-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.